Arrow Mark Colorado Holdings LLC C4 Therapeutics, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$7.03 Billion
Q3 2024

A detailed history of Arrow Mark Colorado Holdings LLC transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 1,319,484 shares of CCCC stock, worth $5.21 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

1,319,484

Previous 1,244,358 6.04%

Holding current value

$5.21 Million

Previous $5.75 Million 30.85%

% of portfolio

0.11%

Previous 0.08%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.43 - $7.38 $332,808 - $554,429	75,126 Added 6.04%	1,319,484 $7.52 Million
Q2 2024 Aug 14, 2024	SELL	$4.05 - $8.1 $192,703 - $385,406	-47,581 Reduced 3.68%	1,244,358 $5.75 Million
Q1 2024 May 15, 2024	SELL	$5.3 - $11.0 $4.48 Million - $9.3 Million	-845,442 Reduced 39.56%	1,291,939 $10.6 Million
Q4 2023 Feb 14, 2024	BUY	$1.18 - $6.03 $2.16 Million - $11 Million	1,827,626 Added 590.02%	2,137,381 $12.1 Million
Q2 2023 Aug 14, 2023	SELL	$2.75 - $3.77 $16.7 Million - $22.9 Million	-6,071,125 Reduced 95.15%	309,755 $851,000
Q1 2023 May 15, 2023	BUY	$3.1 - $9.02 $1.79 Million - $5.21 Million	578,009 Added 9.96%	6,380,880 $20 Million
Q4 2022 Feb 14, 2023	BUY	$5.42 - $10.24 $3.85 Million - $7.28 Million	710,896 Added 13.96%	5,802,871 $34.2 Million
Q3 2022 Nov 14, 2022	SELL	$8.03 - $12.77 $6.03 Million - $9.58 Million	-750,432 Reduced 12.84%	5,091,975 $44.7 Million
Q2 2022 Aug 15, 2022	BUY	$5.06 - $26.46 $19.9 Million - $104 Million	3,933,384 Added 206.04%	5,842,407 $44.1 Million
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $2.69 Million - $4.47 Million	134,519 Added 7.58%	1,909,023 $46.3 Million
Q4 2021 Feb 14, 2022	BUY	$29.39 - $46.86 $7.64 Million - $12.2 Million	259,884 Added 17.16%	1,774,504 $57.1 Million
Q3 2021 Nov 15, 2021	BUY	$35.91 - $50.5 $4.27 Million - $6.01 Million	118,999 Added 8.53%	1,514,620 $67.7 Million
Q2 2021 Aug 16, 2021	BUY	$30.39 - $42.18 $34.8 Million - $48.3 Million	1,144,004 Added 454.66%	1,395,621 $52.8 Million
Q1 2021 May 17, 2021	BUY	$31.96 - $46.5 $78,877 - $114,762	2,468 Added 0.99%	251,617 $9.31 Million
Q4 2020 Feb 16, 2021	BUY	$22.8 - $37.05 $5.68 Million - $9.23 Million	249,149 New	249,149 $8.25 Million

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $193M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account

Arrow Mark Colorado Holdings LLC C4 Therapeutics, Inc. Transaction History